SNMMI and three other organizations, including the International Atomic Energy Agency, launched the Nuclear Medicine Technologists in Theranostics International Consortium. The consortium will focus on setting global standards for nuclear medicine technologists in theranostics. The initiative will involve data collection, consensus publications and practical guidance to support NMT roles in theranostics.

A study published in The Journal of Nuclear Medicine explores factors affecting the accuracy of Centiloid conversion in amyloid PET imaging. The study found that sample size and image resolution significantly impact measurement errors in Centiloid conversion. 

A Phase 3 study found that adding lutetium-177 PSMA-617 to standard hormone therapy significantly improved radiographic progression-free survival in men with newly diagnosed metastatic hormone-sensitive prostate cancer, compared with standard hormone therapy alone, researchers reported at the European Society for Medical Oncology's annual meeting. Dr. Scott Tagawa said that "we're seeing benefits consistent with prior trials in later disease stages, but now brought forward to the frontline."

A review in the Journal of Nanobiotechnology covered advancements in theranostic nanomaterials for traumatic brain injury. These nanomaterials are designed to combine diagnostic and therapeutic functions to improve neuroprotection and target drug delivery. "By providing a means for simultaneous diagnosis and therapy, theranostic nanomaterials hold the promise of improving clinical outcomes, while deepening our understanding of the underlying mechanisms of brain injury," researchers wrote.

Primo Biotechnology and GE Healthcare have agreed to work together to develop new radiopharmaceuticals. The partnership involves licensing, co-development, technology transfer, manufacturing and commercialization, with GE Healthcare prioritizing licensing to Primo for development in Taiwan.

A study of 25 million privately insured adults found colorectal cancer screening trends shifted after the onset of the pandemic, with decreases in colonoscopy and fecal immunochemical test use and a rise in stool DNA testing. The research in JAMA Network Open found disparities in screening preferences by sex, socioeconomic status and metropolitan versus nonmetropolitan residence.

King Faisal Specialist Hospital and Research Centre and Eli Lilly have agreed to develop, manufacture and commercialize florbetapir F-18, which is used with PET imaging to detect amyloid plaques in patients with Alzheimer's disease. The goal is to increase access to advanced amyloid PET imaging in Saudi Arabia.

A New Drug Application for MK-6240, a tau PET imaging radiodiagnostic that targets aggregated tau protein in the form of neurofibrillary tangles, was accepted by the FDA. The Prescription Drug User Fee Act target action date has been set at Aug. 13, 2026.

Nvidia has added new open models to its Clara suite of AI applications, including imaging tools developed in collaboration with the National Institutes of Health. Clara Reason, a vision language model, is designed to enhance explainability in imaging AI, while Clara Segment enables interactive 3D segmentation and annotation. NIH is integrating the Reason models into radiology workflows.